13 research outputs found
Baseline Results from Hawaii's NÄ Mikiniiki Project: A Physical Activity Intervention Tailored to Multiethnic Postpartum Women
During the postpartum period, ethnic minority women have higher rates of inactivity/under-activity than white women. The NÄ Mikimiki (âthe active onesâ) Project is designed to increase moderate-to-vigorous physical activity over 18 months among multiethnic women with infants 2â12 months old. The study was designed to test, via a randomized controlled trial, the effectiveness of a tailored telephone counseling of moderate-to-vigorous physical activity intervention compared to a print/website materials-only condition. Healthy, underactive women (mean age = 32 ± 5.6 years) with a baby (mean age = 5.7 ± 2.8 months) were enrolled from 2008â2009 (N = 278). Of the total sample, 84% were ethnic minority women, predominantly AsianâAmerican and Native Hawaiian. Mean self-reported baseline level of moderate-to-vigorous physical activity was 40 minutes/week with no significant differences by study condition, ethnicity, infant's age, maternal body mass index, or maternal employment. Women had high scores on perceived benefits, self-efficacy, and environmental support for exercise but low scores on social support for exercise. This multiethnic sample's demographic and psychosocial characteristics and their perceived barriers to exercise were comparable to previous physical activity studies conducted largely with white postpartum women. The NÄ Mikimiki Project's innovative tailored technology-based intervention and unique population are significant contributions to the literature on moderate-to-vigorous physical activity in postpartum women
Effectiveness of a 12-month randomized clinical trial to increase physical activity in multiethnic postpartum women: Results from Hawaii's NÄ Mikimiki Project
Objective. Few postpartum ethnic minority women perform leisure-time moderate-to-vigorous physical activity (MVPA). The study tested the effectiveness of a 12-month tailored intervention to increase MVPA in women with infants 2-12 months old